特發信息(000070.SZ):目前公司光模塊產品未進入華為供應商
格隆匯4月21日丨有投資者在投資者互動平台向特發信息(000070.SZ)提問,“人工智能時代來臨,算力成為關鍵,光模塊又是中國的科技機會,請問特發信息在這方面技術儲備怎麼樣,和華為的合作是否順利。”
特發信息回覆稱,公司持續關注算力基礎設施及相關產品的發展,去年投資的華嶺光子,主要提供100G 及以上產品生產製造,擁有COB/BOX 平台,可以支持400G/800G/1.6T等產品設計開發製造,補齊高速光模塊和光器件產品線。目前公司光模塊產品未進入華為供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.